Officials from York Instruments, a subsidiary of Croton Healthcare based in Coral Springs, Fla., announced that the company has entered into an agreement with eemagine for the development of high-performance integrated solutions to study human electromagnetic brain activity using magnetoencephalography (MEG) and electroencephalography (EEG) for research and clinical diagnostics.
This joint effort enables York Instruments to provide users with high-resolution EEG measurements and clinical analysis software, which complements the company’s advanced MEG solutions.
MEG and EEG are non-invasive measurement techniques that unravel neuronal activity in the human cortex with great temporal and spatial detail. MEG in combination with EEG plays a key role in presurgical evaluation of epilepsy patients and is increasingly being used to study other challenging neurodegenerative disorders, such as Alzheimer’s. The combination of state-of-the-art MEG and EEG technologies makes this technique very effective for routine clinical use.
“We are delighted to enter into this agreement with a focused and ambitious partner in the MEG industry,” said Frank Zanow, CEO of eemagine. “Our company has a long history in MEG analysis software and vast expertise using EEG data with our ASA software and eego EEG amplifier line, as brought to the market by ANT Neuro b.v., a leading supplier in neuroscience.”
York Instruments’ president James R. Petite Jr. said that he welcomed the inclusion of the MEGSCAN clinical software package and EEG amplifier components by ANT Neuro as a valuable addition to the MEGSCAN product offering.
[Want to stay more on top of MDO content? Subscribe to our weekly e-newsletter.]